Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trialAmi E. Iskandrian, Whedy Wang, João V. Vítola et al.|Journal of Nuclear Cardiology|2007Cited by 345
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable anginaCindy L. Grines, Neal S. Kleiman, Matthew W. Watkins et al.|Journal of the American College of Cardiology|2003Cited by 290
Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imagingGary V. Heller, William VanDecker, Timothy M. Bateman et al.|Journal of Nuclear Cardiology|2004Cited by 136
Regadenoson Induces Comparable Left Ventricular Perfusion Defects as AdenosineJohn J. Mahmarian, Ann Olmsted, Manuel D. Cerqueira et al.|JACC. Cardiovascular imaging|2009Cited by 132
Initial Clinical Experience With Regadenoson, a Novel Selective A2AAgonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion ImagingRobert C. Hendel, John J. Mahmarian, Ami E. Iskandrian et al.|Journal of the American College of Cardiology|2005Cited by 128